Literature DB >> 19933721

Oxidative stress and homocysteine metabolism in patients with lupus nephritis.

G Moroni1, C Novembrino, S Quaglini, R De Giuseppe, B Gallelli, V Uva, V Montanari, P Messa, F Bamonti.   

Abstract

The objective of this study was to compare oxidative status and homocysteinemia in patients with lupus nephritis (LN) and in controls. Total antioxidant capacity (TAC), reactive oxygen species (ROS), homocysteine and related vitamins were measured in 68 patients with LN and in 50 controls. LN patients had lower TAC (p = 0.05) and higher ROS and homocysteinemia (p = 0.01) than controls. TAC, significantly lower in active than in quiescent LN (p = 0.01), was correlated with albuminemia (p = 0.02), inversely with proteinuria (p = 0.01) and anti-DNA antibodies (p = 0.004). ROS values, higher both in active and in inactive LN, correlated with age (p = 0.02), C-reactive protein (CRP) (p = 0.0005) and inversely with prednisone dosage (p = 0.05). At multivariate analysis, CRP (p = 0.04) and age (p = 0.005) were independent ROS predictors. Homocysteine, higher in active than in quiescent LN (p = 0.016) and in patients with antiphospholipid antibodies (p=0.05), correlated with serum creatinine (p = 0.00001) and proteinuria (p = 0.015). At multivariate analysis serum creatinine (p = 0.006) and active nephritis (p = 0.003) were independent predictors of hyperhomocysteinemia. Patients with LN showed impaired oxidative status, even without clinical signs of renal activity. ROS production may be counterbalanced by adequate antioxidant capacity in some patients with quiescent LN. The association of hyperhomocysteinemia and antiphospholipid antibodies positivity may increase the risk of cardiovascular and/or thrombotic events in LN patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19933721     DOI: 10.1177/0961203309346906

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  16 in total

1.  Homocysteine levels are independently associated with damage accrual in systemic lupus erythematosus patients from a Latin-American cohort.

Authors:  Paola A Zeña-Huancas; Haydee Iparraguirre-López; Rocío V Gamboa-Cárdenas; Cristina Reátegui-Sokolova; Francisco Zevallos-Miranda; Mariela Medina-Chinchon; Victor R Pimentel-Quiroz; Claudia Elera-Fitzcarrald; Omar Sarmiento-Velasquez; Jorge M Cucho-Venegas; José L Alfaro-Lozano; Zoila J Rodríguez-Bellido; César A Pastor-Asurza; Risto A Perich-Campos; Graciela S Alarcón; Manuel F Ugarte-Gil
Journal:  Clin Rheumatol       Date:  2018-12-12       Impact factor: 2.980

Review 2.  Why are kids with lupus at an increased risk of cardiovascular disease?

Authors:  Catherine Quinlan; Stephen D Marks; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2015-09-23       Impact factor: 3.714

3.  Prevention of murine lupus nephritis by targeting multiple signaling axes and oxidative stress using a synthetic triterpenoid.

Authors:  Tianfu Wu; Yujin Ye; So-Youn Min; Jiankun Zhu; Elhaum Khobahy; Jason Zhou; Mei Yan; Sriram Hemachandran; Simanta Pathak; Xin J Zhou; Michael Andreeff; Chandra Mohan
Journal:  Arthritis Rheumatol       Date:  2014-11       Impact factor: 10.995

Review 4.  Endothelial function and endothelial progenitor cells in systemic lupus erythematosus.

Authors:  Anselm Mak; Jerry Kok Yen Chan
Journal:  Nat Rev Rheumatol       Date:  2022-04-07       Impact factor: 20.543

5.  NADPH oxidase and nitric oxide synthase-dependent superoxide production is increased in proliferative lupus nephritis.

Authors:  J C Oates; A K Mashmoushi; S R Shaftman; G S Gilkeson
Journal:  Lupus       Date:  2013-10-08       Impact factor: 2.911

Review 6.  Oxidative stress in the pathology and treatment of systemic lupus erythematosus.

Authors:  Andras Perl
Journal:  Nat Rev Rheumatol       Date:  2013-10-08       Impact factor: 20.543

7.  Acatalasemic mice are mildly susceptible to adriamycin nephropathy and exhibit increased albuminuria and glomerulosclerosis.

Authors:  Keiichi Takiue; Hitoshi Sugiyama; Tatsuyuki Inoue; Hiroshi Morinaga; Yoko Kikumoto; Masashi Kitagawa; Shinji Kitamura; Yohei Maeshima; Da-Hong Wang; Noriyoshi Masuoka; Keiki Ogino; Hirofumi Makino
Journal:  BMC Nephrol       Date:  2012-03-25       Impact factor: 2.388

8.  Nrf2 suppresses lupus nephritis through inhibition of oxidative injury and the NF-κB-mediated inflammatory response.

Authors:  Tao Jiang; Fei Tian; Hongting Zheng; Samantha A Whitman; Yifeng Lin; Zhigang Zhang; Nong Zhang; Donna D Zhang
Journal:  Kidney Int       Date:  2013-09-11       Impact factor: 10.612

9.  Serum thiols as a biomarker of disease activity in lupus nephritis.

Authors:  Pritesh Lalwani; Giselle Katiane Bonfim Bacelar de Souza; Domingos Savio Nunes de Lima; Luiz Fernando Souza Passos; Antonio Luiz Boechat; Emerson Silva Lima
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

Review 10.  Preventive and therapeutic effects of MG132 by activating Nrf2-ARE signaling pathway on oxidative stress-induced cardiovascular and renal injury.

Authors:  Wenpeng Cui; Yang Bai; Ping Luo; Lining Miao; Lu Cai
Journal:  Oxid Med Cell Longev       Date:  2013-03-07       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.